< Back to previous page
Researcher
Peter Verhamme
- Disciplines:Cardiac and vascular medicine, Molecular and cell biology
Affiliations
- Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 29
- External and Internal Drivers of Unhealthy AgeingFrom8 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting Immunothrombosis in Staphylococcus Aureus Infections and EndocarditisFrom1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Targeting Immunothrombosis in Staphylococcus aureus infections and endocarditisFrom1 Oct 2020 → TodayFunding: BOF - projects
- Investigating the impact of neutrophil extracellular traps and peptidylarginine deiminase 4 in Gram-positive sepsisFrom3 Aug 2020 → TodayFunding: FWO fellowships
- Calming the storm: treating hypercoagulability and hyperinflammation in patients with COVID-19From22 May 2020 → 21 May 2021Funding: FWO thematic call for applied research
- Neutrophil extracellular traps in cardiac fibrosis - Peptidylarginine deiminase 4 and neutrophil extracellular traps in chronic inflammation and cardiac fibrosisFrom1 Oct 2019 → 6 Oct 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Thromboinflammation in Cardiovascular DiseasesFrom1 Aug 2019 → 20 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Assessment and risk stratification of ageing-related target organ damage and adverse health outcomes in the general populationFrom1 May 2019 → 18 Nov 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Tranexamic Acid To Reduce Bleeding in Patients Treated with New Oral AnticoagulantsFrom1 Oct 2017 → 30 Sep 2020Funding: FWO Applied Biomedical Research (TBM)
- The influence of anticoagulants on bleeding and healing after dental extractionFrom1 Sep 2017 → 20 Sep 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
21 - 30 of 442
- INFLAMMATION MARKERS AS POTENTIAL MEDIATORS FOR THE ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND OBESITY(2023)
Authors: Thomas Vanassche, Lucas Van Aelst, Peter Verhamme
Pages: E102 - E102 - From bad to worse: the shortage of fibrinolytics(2023)
Authors: Lorenz Van der Linden, Thomas Vanassche, Robin Lemmens, Peter Verhamme
Pages: 125 - 126 - Long-term outcomes after traumatic brain injury in elderly patients on antithrombotic therapy(2023)
Authors: Peter Verhamme, Bart Depreitere
Pages: 1297 - 1307 - Intermediate-Dose Versus Low-Dose Low-Molecular-Weight Heparin in Pregnant and Post-Partum Women with a History of Venous Thromboembolism (Highlow Study): An Open-Label, Multicentre, Randomised, Controlled Trial(2023)
Authors: Peter Verhamme
Pages: 259 - 261 - Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study(2023)
Authors: Dongmei Wei, Peter Verhamme, Lucas Van Aelst, Thomas Vanassche
- Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis(2023)
Authors: Christophe Vandenbriele, Peter Verhamme, Thomas Vanassche
Pages: 490 - 498 - Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience(2023)
Authors: Veerle Labarque, Thomas Vanassche, Chris Van Geet, Peter Verhamme, Kathelijne Peerlinck, Kathleen Freson
Pages: 887 - 895 - Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors(2023)
Authors: Peter Verhamme
Pages: 1026 - 1038 - Insights into the Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Older Adults with Atrial Fibrillation: A Structured Narrative Review(2023)
Authors: Nada Dia, Erwin Dreesen, Thomas Vanassche, Peter Verhamme, Lorenz Van der Linden, Jos Tournoy
Pages: 351 - 373 - Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag(2023)
Authors: Christophe Vandenbriele, Peter Verhamme
Patents
1 - 1 of 1